Antonio Giordano

Professor and DIrector

Temple University

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Antonio Giordano is a Professor and Director at Temple University in the United States. His research interests encompass cancer biology, cardiovascular disease, and the application of machine learning in biomedical research, as reflected in his recent articles. His work includes investigating the mechanisms of DNA damage in cancer cells, the interplay between atrial fibrillation and cancer, and the development of computational tools for drug target prediction.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (22)

Francesca Pentimalli

Associate Professor of General Pathology

LUM University

ITALY

Antonio Giordano

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines

Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients

Atrial Fibrillation and Cancer: Pathophysiological Mechanism and Clinical Implications

A Machine Learning Platform for Isoform-Specific Identification and Profiling of Human Carbonic Anhydrase Inhibitors

The New Frontier in Small-Cell Lung Cancer: Can Atezolizumab Ensure Enduring Stability?

KinasePred: A Computational Tool for Small-Molecule Kinase Target Prediction

Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence

Hepatitis E and Potential Public Health Implications from a One-Health Perspective: Special Focus on the European Wild Boar (<i>Sus scrofa</i>)

Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell Death

Insights into CSF-1R Expression in the Tumor Microenvironment

Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications

Progranulin Oncogenic Network in Solid Tumors

Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?

Human-Animal Interaction in Animal-Assisted Interventions (AAI)s: Zoonosis Risks, Benefits, and Future Directions—A One Health Approach

The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers?

Neuro–Immune Interactions in Severe COVID-19 Infection

A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma

Analysis of Primary Cilium Expression and Hedgehog Pathway Activation in Mesothelioma Throws Back Its Complex Biology

Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 2.0

Virtual Reality Rehabilitation Systems for Cancer Survivors: A Narrative Review of the Literature

Collaborators (22)

Francesca Pentimalli

Raffaele Cucciniello

raffaele marfella

Annamaria Cimini

Giovanni Nassa

Vincenzo Russo

Marcellino Monda

Orlando Paciello

Bruno TILOCCA

Luigi Alfano

Luciano Mutti

Stefano Landi

Renato V. Iozzo

Luciano Giaco'

Paola Roncada

Luca Rinaldi

Antonino BELFIORE

Andrea Morrione

Domenico Britti

Andrea Chirico

Patrizia Maiorano

Ferdinando Carlo Sasso

Make your next move.